Anika Therapeutics (ANIK) Equity Ratio: 2010-2025
Historic Equity Ratio for Anika Therapeutics (ANIK) over the last 15 years, with Sep 2025 value amounting to 0.77.
- Anika Therapeutics' Equity Ratio fell 0.30% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year decrease of 0.30%. This contributed to the annual value of 0.76 for FY2024, which is 3.16% down from last year.
- Anika Therapeutics' Equity Ratio amounted to 0.77 in Q3 2025, which was down 1.51% from 0.79 recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Equity Ratio registered a high of 0.84 during Q1 2022, and its lowest value of 0.76 during Q4 2024.
- Moreover, its 3-year median value for Equity Ratio was 0.79 (2025), whereas its average is 0.79.
- Its Equity Ratio has fluctuated over the past 5 years, first climbed by 20.62% in 2021, then fell by 5.70% in 2024.
- Quarterly analysis of 5 years shows Anika Therapeutics' Equity Ratio stood at 0.83 in 2021, then fell by 0.98% to 0.82 in 2022, then decreased by 4.11% to 0.78 in 2023, then declined by 3.16% to 0.76 in 2024, then fell by 0.30% to 0.77 in 2025.
- Its Equity Ratio was 0.77 in Q3 2025, compared to 0.79 in Q2 2025 and 0.78 in Q1 2025.